AU Stock MarketDetailed Quotes

CHM Chimeric Therapeutics Ltd

Watchlist
  • 0.014
  • 0.0000.00%
20min DelayTrading Sep 30 16:00 AET
12.67MMarket Cap-777P/E (Static)

Chimeric Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(FY)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
29.22%3.05M
29.22%3.05M
-87.15%2.36M
-87.15%2.36M
-17.98%18.38M
--18.38M
--22.41M
-Cash and cash equivalents
29.22%3.05M
29.22%3.05M
-87.15%2.36M
-87.15%2.36M
-17.98%18.38M
--18.38M
--22.41M
-Accounts receivable
225.25%86.59K
225.25%86.59K
-99.00%26.62K
-99.00%26.62K
10,861.66%2.66M
--2.66M
--24.25K
-Other receivables
-12.07%2.99M
-12.07%2.99M
103.92%3.41M
103.92%3.41M
67.87%1.67M
--1.67M
--994.88K
Total current assets
-65.54%3.22M
-65.54%3.22M
-55.83%9.35M
-55.83%9.35M
-6.59%21.17M
--21.17M
--22.67M
Non current assets
-Goodwill
-7.46%12.01M
-7.46%12.01M
-4.94%12.98M
-4.94%12.98M
-1.25%13.65M
--13.65M
--13.83M
Regulatory assets
-98.70%86.59K
-98.70%86.59K
150.52%6.66M
150.52%6.66M
10,861.66%2.66M
--2.66M
--24.25K
Liabilities
Current liabilities
-accounts payable
-56.78%3.2M
-56.78%3.2M
57.47%7.41M
57.47%7.41M
130.78%4.7M
--4.7M
--2.04M
-Total tax payable
33.81%2.71M
33.81%2.71M
1,225.52%2.02M
1,225.52%2.02M
-96.20%152.57K
--152.57K
--4.02M
Current liabilities
-31.28%10.1M
-31.28%10.1M
62.87%14.69M
62.87%14.69M
22.65%9.02M
--9.02M
--7.35M
Non current liabilities
Non current accrued expenses
-87.77%685
-87.77%685
-64.97%5.6K
-64.97%5.6K
17.33%15.99K
--15.99K
--13.63K
Preferred securities outside stock equity
-30.21%306.6K
-30.21%306.6K
126.51%439.34K
126.51%439.34K
211.66%193.96K
--193.96K
--62.24K
Total non current liabilities
-23.40%12.8M
-23.40%12.8M
82.21%16.71M
82.21%16.71M
-19.35%9.17M
--9.17M
--11.37M
Shareholders'equity
Share capital
17.77%63.51M
17.77%63.51M
4.10%53.93M
4.10%53.93M
38.65%51.81M
--51.81M
--37.37M
-common stock
17.77%63.51M
17.77%63.51M
4.10%53.93M
4.10%53.93M
38.65%51.81M
--51.81M
--37.37M
Gains losses not affecting retained earnings
-35.16%5.52M
-35.16%5.52M
78.73%8.51M
78.73%8.51M
61.90%4.76M
--4.76M
--2.94M
Other equity interest
-75.04%82.51K
-75.04%82.51K
151.55%330.57K
151.55%330.57K
-43.02%131.42K
--131.42K
--230.62K
Total equity
-31.74%15.27M
-31.74%15.27M
-35.85%22.38M
-35.85%22.38M
-4.45%34.88M
--34.88M
--36.5M
(FY)Jun 30, 2024(Q4)Jun 30, 2024(FY)Jun 30, 2023(Q4)Jun 30, 2023(FY)Jun 30, 2022(Q4)Jun 30, 2022(FY)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments 29.22%3.05M29.22%3.05M-87.15%2.36M-87.15%2.36M-17.98%18.38M--18.38M--22.41M
-Cash and cash equivalents 29.22%3.05M29.22%3.05M-87.15%2.36M-87.15%2.36M-17.98%18.38M--18.38M--22.41M
-Accounts receivable 225.25%86.59K225.25%86.59K-99.00%26.62K-99.00%26.62K10,861.66%2.66M--2.66M--24.25K
-Other receivables -12.07%2.99M-12.07%2.99M103.92%3.41M103.92%3.41M67.87%1.67M--1.67M--994.88K
Total current assets -65.54%3.22M-65.54%3.22M-55.83%9.35M-55.83%9.35M-6.59%21.17M--21.17M--22.67M
Non current assets
-Goodwill -7.46%12.01M-7.46%12.01M-4.94%12.98M-4.94%12.98M-1.25%13.65M--13.65M--13.83M
Regulatory assets -98.70%86.59K-98.70%86.59K150.52%6.66M150.52%6.66M10,861.66%2.66M--2.66M--24.25K
Liabilities
Current liabilities
-accounts payable -56.78%3.2M-56.78%3.2M57.47%7.41M57.47%7.41M130.78%4.7M--4.7M--2.04M
-Total tax payable 33.81%2.71M33.81%2.71M1,225.52%2.02M1,225.52%2.02M-96.20%152.57K--152.57K--4.02M
Current liabilities -31.28%10.1M-31.28%10.1M62.87%14.69M62.87%14.69M22.65%9.02M--9.02M--7.35M
Non current liabilities
Non current accrued expenses -87.77%685-87.77%685-64.97%5.6K-64.97%5.6K17.33%15.99K--15.99K--13.63K
Preferred securities outside stock equity -30.21%306.6K-30.21%306.6K126.51%439.34K126.51%439.34K211.66%193.96K--193.96K--62.24K
Total non current liabilities -23.40%12.8M-23.40%12.8M82.21%16.71M82.21%16.71M-19.35%9.17M--9.17M--11.37M
Shareholders'equity
Share capital 17.77%63.51M17.77%63.51M4.10%53.93M4.10%53.93M38.65%51.81M--51.81M--37.37M
-common stock 17.77%63.51M17.77%63.51M4.10%53.93M4.10%53.93M38.65%51.81M--51.81M--37.37M
Gains losses not affecting retained earnings -35.16%5.52M-35.16%5.52M78.73%8.51M78.73%8.51M61.90%4.76M--4.76M--2.94M
Other equity interest -75.04%82.51K-75.04%82.51K151.55%330.57K151.55%330.57K-43.02%131.42K--131.42K--230.62K
Total equity -31.74%15.27M-31.74%15.27M-35.85%22.38M-35.85%22.38M-4.45%34.88M--34.88M--36.5M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data